Fingerprint
Dive into the research topics of 'FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia
Hayley S. Ma, Bao Nguyen, Amy S. Duffield, Li Li, Allison Galanis, Allen B. Williams, Patrick A. Brown, Mark J. Levis, Daniel J. Leahy, Donald Small
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations